I can start. Our commitments are similar to what was outlined in the pan-Canadian framework, so we have responsibilities for surveillance, and we have responsibilities for antimicrobial stewardship and infection prevention and control. We equally have responsibilities to develop policies that support public awareness and change, and the pan-Canadian framework supports research and innovation along with that.
Because there are low-income and middle-income countries in addition to high-income countries in the United Nations and WHO agreements, the bar is actually relatively low. I can tell you that there are many countries, including the U.S., the United Kingdom, Australia, Germany, the Netherlands, Scandinavian countries, etc., that are putting in substantially more relative investment than Canada is, and have already started significant work and put in significant investments. In the U.S. alone, there's a presidential advisory committee on AMR with important national leaders getting together and advising on where investments should go. We don't have the investments to advise our leaders on where it should go.